Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Sanofi India

Sanofi India

BSE: 500674|NSE: SANOFI|ISIN: INE058A01010|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 06, 13:22
6996.55
-23.9 (-0.34%)
VOLUME 83
LIVE
NSE
Dec 06, 13:23
7000.00
-19.95 (-0.28%)
VOLUME 1,305
News on Sanofi India
Select Year: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Aventis Pharma sale of 49% in Chiron Behring Vaccines

7.40 pm | 27 Dec 2010 |  Source: Moneycontrol.com

Aventis Pharma sale of 49% shareholding in Chiron Behring Vaccines Private Limited. The Company received sale consideration of Rs. 1007.5 million....

Buy Aventis Pharma; target of Rs 2023: Firstcall Research

9.15 am | 22 Nov 2010 |  Source: Moneycontrol.com

Firstcall Research is bullish on Aventis Pharma and has recommended buy rating on the stock with a target of Rs 2023 in its October 30, 2010 research ...

Aventis sees sales surge in diabetes products

10.28 pm | 10 Nov 2010 |  Source: Reuters

Aventis Pharma India, a unit of French drugmaker Sanofi-Aventis, expects sales of its diabetes products, the firm's fastest growing segment, to jump 2...

Aventis Pharma a market performer: Karvy Stock Broking

3.01 pm | 29 Oct 2010 |  Source: Moneycontrol.com

Karvy Stock Broking has given a market performer rating on Aventis Pharma with a target of Rs 2008 in its October 26, 2010 research report....

Aventis Pharma reports Rs 293.60 crore turnover for quarter ended Sep 2010

5.12 pm | 27 Oct 2010 |  Source: Moneycontrol.com

Aventis Pharma has reported a sales turnover of Rs 293.60 crore and a net profit of Rs 47.30 crore for the quarter ended Sep 2010...

Aventis Pharma Q3 net profit up at Rs 47.3 cr

4.11 pm | 25 Oct 2010 |  Source: Moneycontrol.com

Aventis Pharma has announced its third quarter results. The companys Q3 net profit was up at Rs 47.3 crore versus Rs 43.8 crore, YoY....

Four drugmakers submit bids for Paras Pharma buy

10.00 am | 12 Oct 2010 |  Source: Reuters

Four drugmakers submit bids for ParasGlobal drugmakers GlaxoSmithKline Plc, Sanofi-Aventis, fnvNovartis AG and US based Johnson & Johnson have submitt...

Aventis Pharma Sept qtr PAT seen down at Rs 43.5 cr: MOST

4.09 pm | 09 Oct 2010 |  Source: Moneycontrol.com

Motilal Oswal has come out with its earning estimates on Pharmaceutical sector for the quarter ended September 2010....

Genzyme says Sanofi proposed $69-$80/share price range

9.26 am | 08 Oct 2010 |  Source: Reuters

Genzyme Corp said that Sanofi-Aventis's chief executive had privately opened the door in September to paying as much as USD 80 per share for the US co...

Taisho leads bids for India`s Paras Pharma

11.27 am | 04 Oct 2010 |  Source: Reuters

Japan's Taisho Pharmaceuticals has emerged the top bidder to buy a majority stake in Indian drugmaker Paras Pharmaceuticals, which owns popular brands...

Accumulate Aventis Pharma; target of Rs 2094: A K Stockmart

6.29 pm | 25 Aug 2010 |  Source: Moneycontrol.com

A K Stockmart has recommended accumulate rating on Aventis Pharma with a target of Rs 2094, in its August 17, 2010 research report....

Motilal Oswal neutral on Aventis Pharma

6.32 pm | 21 Jul 2010 |  Source: Moneycontrol.com

Motilal Oswal has recommended neutral rating on Aventis Pharma in its July 20, 2010 research report....

Aventis Pharma a market performer; tgt Rs 2170: Karvy

2.58 pm | 21 Jul 2010 |  Source: Moneycontrol.com

Karvy Stock Broking has recommended market performer rating on Aventis Pharma with a target price of Rs 2170 in its July 20, 2010 research report....

Sell Aventis Pharma; target of Rs 1658: Angel Broking

7.30 pm | 20 Jul 2010 |  Source: Moneycontrol.com

Angel Broking is bearish on Aventis Pharma and has recommended sell rating on the stock with a target of Rs 1658 in its July 19, 2010 research report....

Aventis Pharma Q2 net profit at Rs 42.4 cr

10.09 am | 20 Jul 2010 |  Source: CNBC-TV18

Aventis Pharma has announced its second quarter results of CY10. It has reported net profit at Rs 42.4 crore as against Rs 47.1 crore (YoY)....

Aventis Pharma Q2 net profit down at Rs 42.4 cr

6.07 pm | 19 Jul 2010 |  Source: CNBC-TV18

Aventis Pharma has announced its second quarter results. The company's Q2 net sales were up at Rs 271.5 crore versus Rs 249.9 crore, year-on-year, YoY...

Aventis Pharma Q1 net profit down at Rs 36.10 cr

2.58 pm | 27 Apr 2010 |  Source: Moneycontrol.com

Aventis Pharma has declared its first quarter results. The company's Q1 net profit was down at Rs 36.10 crore versus Rs 40.50 crore, year-on-year, YoY...

Fresenius in license agreement with Sanofi-Aventis

10.08 am | 05 Apr 2010 |  Source: Reuters

Fresenius Kabi Oncology Ltd said on Monday it has entered into a license and settlement agreement with Sanofi-Aventis for injectable drug Eloxatin....

Hoechst to buy UB group stake in Aventis Pharma

1.50 pm | 22 Mar 2010 |  Source: Reuters

Aventis Pharma Ltd said on Monday its promoter Hoechst GmbH plans to raise its stake to 60.37% in the firm by acquiring 10.27% stake from the United B...

Aventis Pharma mkt performer; tgt Rs 1778: Karvy

10.10 am | 26 Feb 2010 |  Source: Moneycontrol.com

Karvy Stock Broking has given a market performer rating on Aventis Pharma, with a price target of Rs 1778, in its report dated February 26, 2010. The ...

1 2
Quick Links for Sanofi India
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.